The regulation of the collagen II gene was investigated by transfecting plasmids containing potential regulatory sequences of this gene coupled to the gene for chloramphenicol acetyltransferase (CAT) into various cells. The 5' flanking region of this gene functioned as a weak promoter when transfected into chicken chondrocytes or fibroblasts. Inclusion of an 800-base fragment from the first intron, however, increased transcription of CAT =18-fold in chicken chondrocytes and in differentiating limb bud cells but not in fibroblasts, myoblasts, muscle-derived fibroblasts, or teratocarcinoma cells. Furthermore, this fragment was active when placed either upstream or downstream of the CAT gene and when present in either orientation. The activity ofthis enhancer was examined in relation to differentiation by using "micromass" culture of limb bud mesenchyme cells undergoing chondrogenesis. In this system, no response to the enhancer was observed in undifferentiated limb bud mesenchyme cells. Following differentiation into chondrocytes, a 13-fold enhancer effect was observed in these cells. Finally, all-trans-retinoic acid, a known teratogen, dramatically suppressed enhancer activity in chondrocytes and differentiating limb bud mesenchyme cells. These results suggest that the collagen II gene contains an enhancer element in the first intron that is involved in cell-specific expression.
Collagen is the major structural constituent of extracellular matrices. There are at least 11 different types of collagen and many show a specific cell or tissue localization (1) . Collagen II is a cartilage-specific protein, although it is also found in certain portions of the eye (2) . The collagen II gene is initially expressed in specialized embryonic cells that have chondrogenic potential, such as those present in the somites, notochord, and limb bud (3) . High levels ofexpression ofthis gene occur only in the differentiated chondrocyte, and collagen II comprises 40% of the protein in the cartilage matrix. Little is known about how the collagen II gene is regulated. Collagen II is down-regulated in certain diseases and by agents such as retinoic acid (4) .
DNA sequences involved in the initiation of transcription have been located in the 5' flanking region of many genes (5) (6) (7) (8) (9) . These sequences, termed promoters, may be responsible for cell-type-specific expression, as in the case of the insulin gene (7) , or may be general, as, for example, the Rous sarcoma virus (RSV) long terminal repeat (LTR) (5) . Sequences responsible for increased transcription, termed enhancers, have been described for a variety of genes (7, (10) (11) (12) (13) (14) . These elements are often located in the 5' flanking region of the gene (7, 10, 11) but have been found in the 3' flanking region (12) and in introns (13) . In some (7, 11, 13, 14) , but not all (12) , cases, the enhancer functions in a cell-or tissue-specific manner.
Here we report studies on the transcription of the chloramphenicol acetyltransferase (CAT) gene coupled to 5' sequences of the collagen II promoter following its transfection into chondrocytes, embryonic limb bud cells, and other types of cells. Only low transcriptional activity was observed with these constructs. Various fragments covering 6 kilobases (kb) of the first intron were incorporated into a construct containing a 310-base-pair (bp) 5' promoter fragment of the collagen II gene coupled to the CAT gene. Certain fragments of the intron strongly increased the transcription of this promoter in chondrocytes and in differentiating limb bud cells but not in several other types of cells. The activity of an 800-bp fragment of the first intron of the collagen II gene suggests that it is a cartilage-specific enhancer.
MATERIALS AND METHODS
Construction of Collagen II Promoter-CAT Plasmids. For construction of pCII1, pCII2, and pCII3, restriction fragments BamHI-Sma I, Ava I-Sma I, and HindIII-Sma I from pRgcol2 [pRgcol2 contains a 4-kb genomic fragment from the 5' end of the rat collagen II gene (15) ] were ligated into the HindIII site of pSVOCAT (5) as shown in Fig. 1 . In all cases, the 5' overhangs were filled in by using the Klenow fragment ofDNA polymerase I, and the DNA fragments were attached with HindIII linkers. To construct pCII4, pCII5, and PCII6, a HindIII fragment from pCII1 was subcloned into pUC19. This plasmid was linearized by Ava I; this was followed by digestion for various times with BAL-31 exonuclease and then Nde I linkers were added. Various length fragments were isolated by Nde I and HindIII digestion and cloned into the Nde I-HindIII site of pSVOCAT (Fig. 1) .
Construction of CAT Plasmids Containing Collagen II Intron Fragments Plus the Promoter. The derivatives ofpCII4 containing various restriction fragments from the first intron of the gene are listed in Fig. 2a . After Nde I linkers were added to fragment A (Sma I-Sma I), the DNA fragment was cloned into the Nde I site ofpCII4 and designated as pCII4-A. The ends of fragment B (BamHI-EcoRI), fragment D (EcoRI-HindIII), and fragment E (HindIII-HindIII) were made blunt with T4 DNA polymerase. After Nde I linkers were added, these DNA fragments were cloned into the Nde I site of pCII4, and these plasmids were designated as pCII4-B, pCII4-D (pCII4-Dinv contains the same fragment in the reverse orientation), and pCII4-E, respectively. Fragment C (BamHI-BamHI) was cloned into the BamHI site of pCII4 and designated as pCII4-C (pCII4-Cinv as above).
Proc. Nati. Acad. Sci. USA 84 (1987) 8865 Cell Culture. Chondrocytes were prepared from sterna of day 15 chicken embryos as described (16) . Myoblasts were prepared from day 12 chicken pectoral muscle according to established procedures (17) and were plated on laminin. These cells underwent fusion and formed multinucleated myotubes after 3 days. Fibroblasts were isolated from primary muscle culture by repeated passage on nontreated tissue culture plastic. These cells did not form myotubes. Whole chicken embryo fibroblasts were prepared from day 10 embryos by using trypsin digestion according to established procedures (18) and were used at passage 3. Mesenchymal cells were derived from limb buds of stage 20 chicken embryos and were plated as high-density "micromass" cultures (19) to induce differentiation or as low-density cultures to limit differentiation. F9 teratocarcinoma cells were cultured according to standard protocols and were used at passage 8.
Cell Transfection and CAT Assay. In general, 3 x 106 cells were transfected with 10 ,ug of DNA by the calcium phosphate method (20) -3 hr after plating. The DNA-calcium phosphate precipitate was left on the cells for 3 hr. In some cases, following the transfection period, all-trans-retinoic acid was added at 3 ,ug/ml (0.01 mM). This dose is nontoxic but has been shown to block differentiation of limb bud mesenchyme cells into chondrocytes (16) and also shown to inhibit the transcription of the collagen II gene by chondrocytes (4). The cells were harvested 44 hr after transfection and cell extracts from equal cell numbers were assayed for CAT activity as described (21) .
RESULTS
Promoter Activity of the 5' Flanking Region of the Collagen H Gene. Recombinant plasmids containing various lengths of the 5' flanking region of the collagen II gene fused to the CAT gene were constructed and transfected into cultured chicken chondrocytes. Forty-four hours later, extracts were prepared of the cells and assayed for CAT activity. These studies showed that the flanking region of the collagen II gene from +110 to -1780 (i.e., pCII1) had weak promoter activity ( deletions and contained in plasmids pCII2-pCII6, displayed similar weak activity (Fig. lb) . In contrast, the RSV promoter (LTR) was found to be expressed at a high level in these cells as were the f3-actin and simian virus 40 early promoter constructs (data not shown).
A 310-bp 5' promoter fragment (plasmid pCII4) displayed low promoter activity in chondrocytes, chicken embryo fibroblasts, chicken muscle-derived fibroblasts, and chicken myoblasts but was -4-fold more active when transfected into chicken limb bud mesenchyme cells (Table 1 ). This higher activity was observed whether the cells were plated at high density to induce differentiation into chondrocytes or at low density. These data suggested that the 5' flanking region may be preferentially expressed in cells with chondrogenic potential and that other portions ofthe gene must be responsible for high-level expression in the fully differentiated cell.
Functional Analysis of the First Intron. Since the 5' flanking region of the gene appeared to lack a strong, positive regulatory element, we analyzed the first intron for the presence of an enhancer element. Several restriction fragments were isolated from the first intron and placed at the Nde I site of plasmid pCII4 immediately upstream of the 310-bp fragment from the promoter region of the collagen II Proc. Natl. Acad. Sci. USA 84 (1987) gene or at the BamHI site of this plasmid, which is downstream ofthe CAT gene (Fig. 2a) . These constructs were then transfected into chondrocytes. Fragments A (1.4 kb), B (0.7 kb), and E (2 kb) lacked enhancer activity (data not shown for fragment E). However, constructs containing the overlapping fragments C (1.6 kb) and D (1.4 kb) produced an '18-fold increase of CAT activity when compared to the promoter sequence alone (Fig. 2b) . Stimulation of transcription was observed in constructs with fragment C or D placed in either orientation and in both upstream and downstream positions relative to the collagen II promoter (Fig. 2) . Since fragments D and C overlap, the active sequence(s) must be located in an 800-bp EcoRI-BamHI fragment (shown as a boldface rectangle in Fig. 2a) to pCII4, containing only the promoter. Mesenchyme cells that remained undifferentiated when plated at low density did not display any enhancer activity. As observed with chondrocytes, the enhancer was active in the limb bud cells in an orientation-and position-independent manner (data not shown).
Effect of Retinoic Acid on Enhancer Activity. Retinoic acid is known to disrupt chondrogenesis, to down-regulate collagen II expression at the transcriptional level, and to produce skeletal malformations in animals and in humans (22, 23) . Therefore, the effects of retinoic acid on the expression of promoter and/or enhancer constructs of the collagen II gene were tested. Chondrocytes transfected with either pCII4 (promoter alone) or pCII4-C (promoter plus enhancer) were cultured 48 hr with or without retinoic acid. Nonretinoic acid-treated cells transfected with pCII4 containing the promoter sequence alone displayed weak CAT activity, whereas high activity was observed with the enhancer sequence (1.4 vs. 26.0, Table 2 ). In contrast, cells treated with retinoic acid showed less than a 2-fold response to the enhancer sequence (Table 2) . By comparison, RSV promoter activity was high in control and retinoic acid-treated chondrocytes (not shown). Since retinoic acid is also known to block differentiation of limb bud mesenchyme cells into chondrocytes (24), we tested whether retinoic acid treatment would suppress activation of the enhancer in high-density, limb bud mesenchyme cell culture. Only minimal enhancer activity was observed in limb bud cells plated at high density (7, (10) (11) (12) (13) (14) (15) . In addition, the enhancer element was maximally active in chondrocytes, with little response observed in chicken fibroblast, mouse F9 teratocarcinoma cells, or chicken myoblasts. A variety of viral and cellular enhancers have been described that exhibit tissue-or cell-type-specific activity (7, 11, 14) . This group includes the murine heavy and light chain immunoglobulin gene enhancers, which are also present in the first intron (12) .
The mechanism by which this enhancer functions is not known. In the case of the mouse and human immunoglobulin genes, an octamer sequence is present in the light and heavy chain gene promoters as well as in the enhancer elements of these genes (26) . Gel shift studies have indicated that a nuclear factor binds to these conserved sequences (27) , suggesting an interaction between the promoter and enhancer elements that may facilitate the increased transcription. Preliminary sequence data have indicated the presence of the enhancer "core" sequence (28) in the enhancer element and the promoter region of the collagen II gene. Deletion of either core sequence appears to reduce enhancer activity, suggesting an interaction between these elements, perhaps similar to that described for the immunoglobulin gene enhancer and promoter.
Since the rat collagen II gene enhancer functions well in chicken embryo chondrocytes, there may not be species specificity, indicating evolutionary conservation. A similar observation has been made for the chicken a-crystallin gene enhancer, which, though highly cell specific (11), functions well in mouse lens cells (14) .
Since the collagen II gene enhancer functioned in a cell-type-specific manner, we examined the expression of the enhancer during chondrogenesis. No enhancer activity was observed in limb bud mesenchyme cells plated at low density, conditions under which they remained undifferentiated. However, limb bud mesenchyme cells plated at high density displayed strong enhancer activity when substantial differentiation had occurred. This suggests that the transacting factor(s) required for enhancer activity do not preexist in the stem cells but are activated during differentiation. This activation may involve de novo synthesis of these factors and/or modification of already synthesized proteins. A similar pattern of stage-specific expression has been observed for the chicken a-crystalline gene promoter in transgenic mice (14) . The expression of functionally active regulatory protein(s) may be an important component of differential gene expression during normal differentiation.
Finally, we examined the effect of retinoic acid on enhancer activity in the differentiated chondrocyte and during mesenchymal chondrogenesis. Retinoic acid treatment had little effect on collagen II promoter activity in mesenchyme cells and actually increased promoter activity 3-fold in chondrocytes. More important, the strong enhancer activity observed in chondrocytes was greatly suppressed by retinoic acid. In addition to inhibiting enhancer activity in the differentiated cell, retinoic acid also prevented expression of enhancer activity in limb bud mesenchyme cells plated at high density. How retinoic acid blocks the enhancer activity is not known. It is possible that a retinoic acid binding protein complex (or some other protein factor) binds to the enhancer region and acts as a repressor. Alternatively, retinoic acid treatment may reduce the synthesis of the positive regulatory proteins that bind to this enhancer or produce a modification of these proteins resulting in lack of binding.
The present results suggest that the enhancer sequence in the first intron is an important element regulating collagen II gene expression during differentiation. Cartilage-specific regulatory elements are likely present in other chondrocytespecific genes and may be involved in the coordinate expression of chondrocyte genes during chondrogenesis and in the modulation of the chondrocyte phenotype by agents such as retinoic acid.
